Erratum: Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β-dependent vascular endothelial cadherin tyrosine phosphorylation. [Cardiovasc Diabetol., 13, 1, (2014) (112)] DOI: 10.1186/1475-2840-13-112;Disruption of endothelial adherens junctions by high glucose is mediated by protein kinase C-β-dependent vascular endothelial cadherin tyrosine phosphorylation

Cardiovascular Diabetology

Volumn 13, Issue 1, 2014, Pages

  Haidari, Mehran ^a,b   Zhang, Wei ^b   Willerson, James T ^a,b   Dixon, Richard A F ^b  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Adherens junction; Diabetes; Endothelium; Protein kinase C (PKC); Wnt pathway

Indexed keywords

3 METHYLGLUCOSE; BETA CATENIN; BISINDOLYLMALEIMIDE; CD31 ANTIGEN; CYCLIC AMP; CYCLIN D1; CYTOCHALASIN D; FORSKOLIN; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3BETA; LYMPHOID ENHANCER FACTOR 1; MANNITOL; MITOGEN ACTIVATED PROTEIN KINASE; MYOSIN LIGHT CHAIN; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN KINASE C BETA 1; PROTEIN KINASE C BETA 2; PROTEIN KINASE C DELTA; PROTEIN KINASE C GAMMA; T CELL FACTOR PROTEIN; UNCLASSIFIED DRUG; UROKINASE; VASCULAR ENDOTHELIAL CADHERIN; WNT PROTEIN; ADENYLATE CYCLASE; FOCAL ADHESION KINASE 2; GLYCOGEN SYNTHASE KINASE 3ALPHA; ACTIN; MYOSIN; MYOSIN LIGHT CHAIN 3; PROTEIN KINASE; PROTEIN KINASE C; TYROSINE; CADHERIN; CTNNB1 PROTEIN, HUMAN;

ACTIN POLYMERIZATION; ACUTE MONOCYTIC LEUKEMIA; ARTICLE; CALCIUM CELL LEVEL; CELL JUNCTION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CULTURE MEDIUM; DISSOCIATION; DRUG MEGADOSE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME PHOSPHORYLATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; LEUKEMIA CELL LINE; LUCIFERASE ASSAY; MONOCYTE; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSACTIVATION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING; WNT SIGNALING PATHWAY; CELL DISRUPTION; CLINICAL EVALUATION; CONCENTRATION RESPONSE; ENDOTHELIAL ADHERENS JUNCTION; ENZYME MECHANISM; GENETIC TRANSCRIPTION; MEMBRANE PERMEABILITY; ATTENUATION; DISSOCIATION CONSTANT; HUMAN CELL CULTURE; IN VITRO STUDY; LEUKOCYTE; PROTEIN DEPLETION; PROTEIN INDUCTION; CELL MOTION; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADHERENS JUNCTIONS; BETA CATENIN; CADHERINS; CELL MOVEMENT; ENDOTHELIUM, VASCULAR; GLUCOSE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MONOCYTES; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; PROTEIN KINASE C BETA; TYROSINE;

EID: 84904072181     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/s12933-017-0614-7     Document Type: Erratum

References (49)

1. Libby P. Inflammation in atherosclerosis. Nature 2002, 420:868-874.
2. Jongstra-Bilen J, Haidari M, Zhu SN, Chen M, Guha D, Cybulsky MI. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J Exp Med 2006, 203:2073-2083.
3. Dejana E, Orsenigo F, Lampugnani MG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 2008, 121:2115-2122.
4. Vestweber D. VE-cadherin: the major endothelial adhesion molecule controlling cellular junctions and blood vessel formation. Arterioscler Thromb Vasc Biol 2008, 28:223-232.
5. Kemler R. From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 1993, 9:317-321.
6. Alcaide P, Newton G, Auerbach S, Sehrawat S, Mayadas TN, Golan DE, Yacono P, Vincent P, Kowalczyk A, Luscinskas FW. p120-Catenin regulates leukocyte transmigration through an effect on VE-cadherin phosphorylation. Blood 2008, 112:2770-2779.
7. Schulte D, Kuppers V, Dartsch N, Broermann A, Li H, Zarbock A, Kamenyeva O, Kiefer F, Khandoga A, Massberg S, Vestweber D. Stabilizing the VE-cadherin-catenin complex blocks leukocyte extravasation and vascular permeability. EMBO J 2011, 30:4157-4170.
8. Shen Q, Rigor RR, Pivetti CD, Wu MH, Yuan SY. Myosin light chain kinase in microvascular endothelial barrier function. Cardiovasc Res 2010, 87:272-280.
9. Haidari M, Zhang W, Chen Z, Ganjehei L, Warier N, Vanderslice P, Dixon R. Myosin light chain phosphorylation facilitates monocyte transendothelial migration by dissociating endothelial adherens junctions. Cardiovasc Res 2011, 92:456-465.
10. Vestweber D. Novel insights into leukocyte extravasation. Curr Opin Hematol 2012, 19:212-217.
11. Nathan DM, Lachin J, Cleary P, Orchard T, Brillon DJ, Backlund JY, Oleary DH, Genuth S. Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus. N Engl J Med 2003, 348:2294-2303.
12. Altannavch TS, Roubalova K, Kucera P, Andel M. Effect of high glucose concentrations on expression of ELAM-1, VCAM-1 and ICAM-1 in HUVEC with and without cytokine activation. Physiol Res 2004, 53:77-82.
13. Smolock AR, Mishra G, Eguchi K, Eguchi S, Scalia R. Protein kinase C upregulates intercellular adhesion molecule-1 and leukocyte-endothelium interactions in hyperglycemia via activation of endothelial expressed calpain. Arterioscler Thromb Vasc Biol 2011, 31:289-296.
14. Rattan V, Shen Y, Sultana C, Kumar D, Kalra VK. Glucose-induced transmigration of monocytes is linked to phosphorylation of PECAM-1 in cultured endothelial cells. Am J Physiol 1996, 271:E711-717.
15. Hempel A, Maasch C, Heintze U, Lindschau C, Dietz R, Luft FC, Haller H. High glucose concentrations increase endothelial cell permeability via activation of protein kinase C alpha. Circ Res 1997, 81:363-71.
16. Haidari M, Zhang W, Caivano A, Chen Z, Ganjehei L, Mortazavi A, Stroud C, Woodside DG, Willerson JT, Dixon RA. Integrin alpha2beta1 mediates tyrosine phosphorylation of vascular endothelial cadherin induced by invasive breast cancer cells. J Biol Chem 2012, 287:32981-32992.
17. Haidari M, Zhang W, Chen Z, Ganjehei L, Mortazavi A, Warier N, Vanderslice P, Dixon RA. Atorvastatin preserves the integrity of endothelial adherens junctions by inhibiting vascular endothelial cadherin tyrosine phosphorylation. Exp Cell Res 2012, 318:1673-1684.
18. Di Ciano-Oliveira C, Lodyga M, Fan L, Szaszi K, Hosoya H, Rotstein OD, Kapus A. Is myosin light-chain phosphorylation a regulatory signal for the osmotic activation of the Na + -K + -2Cl- cotransporter?. Am J Physiol Cell Physio 2005, 289:C68-81.
19. Dang L, Seale JP, Qu X. High glucose-induced human umbilical vein endothelial cell hyperpermeability is dependent on protein kinase C activation and independent of the Ca2 + -nitric oxide signalling pathway. Clin Exp Pharmacol Physiol 2005, 32:771-776.
20. Wei L, Yin Z, Yuan Y, Hwang A, Lee A, Sun D, Li F, Di C, Zhang R, Cao F, Wang H. A. PKC-beta inhibitor treatment reverses cardiac microvascular barrier dysfunction in diabetic rats. Microvasc Res 2010, 80:158-165.
21. Haidari M, Zhang W, Wakame K. Reactive Oxygen Species Mediate Disruption of Endothelial Adherens Junction Induced by Invasive Breast Cancer Cells (a mechanism that is attenuated by Active Hexose Correlated Compound. AHCC Life Sci 2013, 18:994-1003. doi:10.1016/j.lfs.2013.10.027.
22. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996, 73:245-248.
23. Aslam M, Hartel FV, Arshad M, Gunduz D, Abdallah Y, Sauer H, Piper HM, Noll T. cAMP/PKA antagonizes thrombin-induced inactivation of endothelial myosin light chain phosphatase: role of CPI-17. Cardiovasc Res 2010, 87:375-384.
24. Moore TM, Chetham PM, Kelly JJ, Stevens T. Signal transduction and regulation of lung endothelial cell permeability. Interaction between calcium and cAMP. Am J Physiol 1998, 275:L203-222.
25. Qiao J, Huang F, Lum H. PKA inhibits RhoA activation: a protection mechanism against endothelial barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 2003, 284:L972-980.
26. Kam Y, Quaranta V. Cadherin-bound beta-catenin feeds into the Wnt pathway upon adherens junctions dissociation: evidence for an intersection between beta-catenin pools. PLoS One 2009, 4:e4580.
27. Huber AH, Weis WI. The structure of the beta-catenin/E-cadherin complex and the molecular basis of diverse ligand recognition by beta-catenin. Cell 2001, 105:391-402.
28. Nelson WJ, Nusse R. Convergence of Wnt, beta-catenin, and cadherin pathways. Science 2004, 303:1483-1487.
29. Molenaar M, van de Wetering M, Oosterwegel M, Peterson-Maduro J, Godsave S, Korinek V, Roose J, Destree O, Clevers H. XTcf-3 transcription factor mediates beta-catenin- induced axis formation in Xenopus embryos. Cell 1996, 86:391-399.
30. Kanter JE, Johansson F, LeBoeuf RC, Bornfeldt KE. Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques?. Circ Res 2007, 100:769-781.
31. Renard CB, Kramer F, Johansson F, Lamharzi N, Tannock LR, von Herrath MG, Chait A, Bornfeldt KE. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest 2004, 114:659-668.
32. Haidari M, Zhang W, Ganjehei L, Ali M, Chen Z. Inhibition of MLC phosphorylation restricts replication of influenza virus-a mechanism of action for anti-influenza agents. PLoS One 2011, 6:e21444.
33. Hirano K. Current topics in the regulatory mechanism underlying the Ca2+ sensitization of the contractile apparatus in vascular smooth muscle. J Pharmacol Sci 2007, 104:109-115.
34. Kimura K, Ito M, Amano M, Chihara K, Fukata Y, Nakafuku M, Yamamori B, Feng J, Nakano T, Okawa K, Iwamatsu A, Kaibuchi K. Regulation of myosin phosphatase by Rho and Rho-associated kinase (Rho-kinase). Science 1996, 273:245-248.
35. Klemke RL, Cai S, Giannini AL, Gallagher PJ, de Lanerolle P, Cheresh DA. Regulation of cell motility by mitogen-activated protein kinase. J Cell Biol 1997, 137:481-492.
36. Lincoln TM. Myosin phosphatase regulatory pathways: different functions or redundant functions?. Circ Res 2007, 100:10-12.
37. Nguyen DH, Catling AD, Webb DJ, Sankovic M, Walker LA, Somlyo AV, Weber MJ, Gonias SL. Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner. J Cell Biol 1999, 146:149-164.
38. Bruewer M, Hopkins AM, Hobert ME, Nusrat A, Madara JL. RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin. Am J Physiol Cell Physiol 2004, 287:C327-335.
39. Miyake Y, Inoue N, Nishimura K, Kinoshita N, Hosoya H, Yonemura S. Actomyosin tension is required for correct recruitment of adherens junction components and zonula occludens formation. Exp Cell Res 2006, 312:1637-1650.
40. Cain RJ, Vanhaesebroeck B, Ridley AJ. The PI3K p110alpha isoform regulates endothelial adherens junctions via Pyk2 and Rac1. J Cell Biol 2010, 188:863-876.
41. Lambeng N, Wallez Y, Rampon C, Cand F, Christe G, Gulino-Debrac D, Vilgrain I, Huber P. Vascular endothelial-cadherin tyrosine phosphorylation in angiogenic and quiescent adult tissues. Circ Res 2005, 96:384-391.
42. Raghunath PN, Tomaszewski JE, Brady ST, Caron RJ, Okada SS, Barnathan ES. Plasminogen activator system in human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 1995, 15:1432-1443.
43. Reichel CA, Uhl B, Lerchenberger M, Puhr-Westerheide D, Rehberg M, Liebl J, Khandoga A, Schmalix W, Zahler S, Deindl E, Lorenzl S, Declerck PJ, Kanse S, Krombach F. Urokinase-type plasminogen activator promotes paracellular transmigration of neutrophils via Mac-1, but independently of urokinase-type plasminogen activator receptor. Circulation 2011, 124:1848-1859.
44. Esser S, Lampugnani MG, Corada M, Dejana E, Risau W. Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells. J Cell Sci 1998, 111:1853-1865.
45. Behzadian MA, Windsor LJ, Ghaly N, Liou G, Tsai NT, Caldwell RB. VEGF-induced paracellular permeability in cultured endothelial cells involves urokinase and its receptor. FASEB J 2003, 17:752-754.
46. Kanse SM, Benzakour O, Kanthou C, Kost C, Lijnen HR, Preissner KT. Induction of vascular SMC proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders. Arterioscler Thromb Vasc Biol 1997, 17:2848-2854.
47. Aguirre Ghiso JA, Kovalski K, Ossowski L. Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling. J Cell Biol 1999, 147:89-104.
48. Tang H, Kerins DM, Hao Q, Inagami T, Vaughan DE. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells. J Biol Chem 1998, 273:18268-18272.
49. Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, Bertrand F, Cherqui G, Perret C, Capeau J. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Oncogene 2001, 20:252-259.